Tema Heart & Health ETF (HRTS) is an ETF managed by Independent / Boutique. Its largest position is ELI LILLY & Co (LLY), representing 10.01% of fund assets.
Tema Heart & Health ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- HRTS
- Type:
- ETF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Feb 28, 2026
- Filing Date:
- Apr 23, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
ELI LILLY & Co
|
10.01% | $5,536,623.37 | 5,263 |
|
-
ROCHE HOLDING AG
|
5.46% | $3,021,567.00 | 50,740 |
|
-
JOHNSON & JOHNSON
|
4.85% | $2,685,528.30 | 10,810 |
|
-
ASTRAZENECA PLC
|
4.81% | $2,661,302.80 | 12,706 |
|
-
Merck & Co., Inc.
|
4.23% | $2,342,426.76 | 18,918 |
|
-
THERMO FISHER SCIENTIFIC INC.
|
3.90% | $2,155,832.07 | 4,137 |
|
-
UNITEDHEALTH GROUP INC
|
3.85% | $2,127,087.31 | 7,253 |
|
-
GILEAD SCIENCES, INC.
|
3.62% | $2,001,143.25 | 13,435 |
|
-
APPLIED MATERIALS INC /DE
|
3.61% | $1,999,636.47 | 11,781 |
|
-
ABBOTT LABORATORIES
|
3.37% | $1,863,577.95 | 16,017 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
3.20% | $1,772,689.44 | 3,568 |
|
-
AbbVie Inc.
|
2.96% | $1,635,003.60 | 7,045 |
|
-
DANAHER CORP /DE/
|
2.92% | $1,612,870.48 | 7,657 |
|
-
BOSTON SCIENTIFIC CORP
|
2.47% | $1,364,010.65 | 17,749 |
|
-
Medtronic plc
|
2.36% | $1,306,397.82 | 13,377 |
|
-
BridgeBio Pharma, Inc.
|
2.23% | $1,234,334.16 | 18,567 |
|
-
Revolution Medicines, Inc.
|
2.21% | $1,223,729.90 | 11,995 |
|
-
BRISTOL MYERS SQUIBB CO
|
2.16% | $1,196,817.93 | 19,189 |
|
-
MCKESSON CORP
|
2.16% | $1,194,717.70 | 1,210 |
|
-
APPLIED MATERIALS INC /DE
|
2.15% | $1,188,408.99 | 31,589 |
|
-
AMGEN INC
|
2.09% | $1,158,269.44 | 2,984 |
|
-
CHUGAI PHARMACEUTICAL CO LTD.
|
2.05% | $1,136,181.63 | 16,971 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
2.01% | $1,114,661.42 | 1,426 |
|
-
Edwards Lifesciences Corp
|
1.86% | $1,027,868.89 | 11,887 |
|
-
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
1.62% | $893,633.12 | 26,392 |
|
-
CYTOKINETICS INC
|
1.47% | $815,579.76 | 13,108 |
|
-
INTUITIVE SURGICAL INC
|
1.47% | $810,651.10 | 1,610 |
|
-
MASIMO CORP
|
1.36% | $751,550.10 | 4,286 |
|
-
DEXCOM INC
|
1.29% | $712,124.14 | 9,698 |
|
-
MADRIGAL PHARMACEUTICALS, INC.
|
1.21% | $670,032.00 | 1,551 |
|
-
INSMED Inc
|
1.19% | $659,590.61 | 4,417 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
1.19% | $656,518.24 | 1,972 |
|
-
INSULET CORP
|
1.04% | $576,080.96 | 2,336 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
1.03% | $567,531.90 | 8,970 |
|
-
Viking Therapeutics, Inc.
|
0.85% | $469,259.28 | 13,867 |
|
-
IONIS PHARMACEUTICALS INC
|
0.83% | $460,363.95 | 5,673 |
|
-
Scholar Rock Holding Corp
|
0.78% | $432,650.71 | 9,773 |
|
-
Ascendis Pharma A/S
|
0.75% | $414,929.50 | 1,777 |
|
-
CRINETICS PHARMACEUTICALS INC
|
0.64% | $355,720.50 | 8,655 |
|
-
FIRST AMERICAN TREASURY OBLIGA
|
0.59% | $325,512.87 | 325,513 |
|
-
NEUROCRINE BIOSCIENCES INC
|
0.57% | $315,680.75 | 2,387 |
|
-
ZEALAND PHARMA AS
|
0.56% | $308,536.18 | 5,363 |
|
-
GUBRA A/S
|
0.51% | $281,025.84 | 4,545 |
|
-
Intellia Therapeutics, Inc.
|
0.35% | $193,967.28 | 14,076 |
Advertisement (320x50)